These data display an unreported correlation of bupivacaine with Akt/mTOR signaling-mediated autophagy in the development of NSCLC, identifying the new mechanism of bupivacaine-induced anti-tumor activity. Here, MTOR is linked to non-small cell lung carcinoma.